Navigation Links
New heart attack definition to be launched at ESC Congress 2012 topics: Myocardial disease

Sophia Antipolis, 16 August 2012: A new definition of heart attack will be presented at the ESC Congress 2012. The third universal definition of myocardial infarction (MI) clarifies the controversial area of procedural related MI and will be the gold standard for diagnosis and clinical trial endpoints.

It's just one of the sessions not to miss at this year's ESC Congress, being held 25-29 August in Munich, Germany.

The Congress kicks off on Saturday 25 August, with a fuller scientific programme than ever. For the first time there is a full press programme on Saturday with three press conferences.

The press conference schedule is packed with the latest science and great news stories. Long awaited results of clinical trials such as ALTITUDE, FAME II, FAST MI, PROTECT, De FACTO, WOEST and TRILOGY ACS will be announced. Other groundbreaking content has been grouped under eight themed headings. New techniques such as Renal Denervation will be among the spotlights of our press conferences: come and hear about how zapping overactive kidney nerves can lower blood pressure in patients who don't respond to drugs. And how politicians can influence lifestyle changes to prevent cardiovascular disease.

Professor Michael Bhm, Chairperson of the ESC Congress Programme Committee, said: "The ESC Congress is the top international cardiovascular event of the year and 2012 has more new science than ever. Hold the front page for results presented in Hot Line sessions. These are some of the most exciting sessions in the cardiovascular calendar and will influence future treatment of heart disease."


Contact: ESC Press Office
European Society of Cardiology

Page: 1

Related medicine news :

1. Witnessing, Experiencing Traumatic Events May Worsen Heart Disease
2. Risk of suicide and fatal heart attack immediately following a cancer diagnosis
3. Cancer Diagnosis May Raise Odds for Suicide, Heart Attack Death
4. In children born with severe heart defect, surgical management has little effect on neuro outcomes
5. Invasive heart test being dramatically overused, Stanford study shows
6. Heart failure patients with diabetes may benefit from higher glucose levels
7. Omega-3 Supplements No Help Against Repeat Heart Trouble: Review
8. EKG Heart Test May Predict Risk in Older Adults
9. Common Blood Pressure Drug Safe for Heart Failure: Study
10. Spouses of Cancer Patients May Have Raised Risk of Heart Disease, Stroke
11. SMART heart eases heart ache, targets cardiac patients emotional well-being
Post Your Comments:
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from reveals ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: